Zirconium
Preclinical / discovery stageRecent clinical, regulatory, research and industry developments relating to this drug.
Trifunctional zirconium catalysis-enabled triple modular synthesis
Radiopaque Intestinal Cast of Sodium Zirconium Cyclosilicate on CT
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Breast cancer research : BCR1
- Clinical cancer research : an official journal of the American Association for Cancer Research1
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine1
- Lewis JS2
- Pandit-Taskar N2
- Aivazian A1
- Barker CA1
- Behera D1
- Bhanot U1
- Biachi De Castria T1
- Bojilova V1
- Memorial Sloan Kettering Cancer Center2
- Weill Cornell Medical College2
- Beckman Research Institute of the City of Hope1
- Harold C. Simmons Comprehensive Cancer Center1
- Marie-Josée & Henry R. Kravis Center for Molecular Oncology1
- O'Neal Comprehensive Cancer Center1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 5 of the same disease areas as Zirconium in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature